In addition, the Human Protein Atlas (https://www.proteinatlas.org/) dataset indicated that high expression levels of NFAT1 were associated with poor prognosis in patients with ccRCC (Fig. 1D). This evidence concerns the gene NFATC2 and nonpapillary renal cell carcinoma.